- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
ErbB2 receptor tyrosine kinase 2 (ERBB2), also known as HER2, is a transmembrane receptor involved in cell signaling, proliferation, and tumor progression. HER2 Antibody / Extracellular Domain Antibody (clone ERBB2/3078) targets this protein and was generated against a region within amino acids 311-462 of HER2, corresponding to an extracellular portion of the receptor. HER2 antibody, also referred to as ErbB2 antibody and ERBB2 antibody in the literature, detects a key signaling receptor frequently studied in cancer biology and epithelial cell function. This antibody is part of a collection of Human Protein Microarray validated antibodies that have been screened for specificity across thousands of proteins.
Functionally, HER2 is a member of the epidermal growth factor receptor family and plays a central role in activating downstream signaling pathways such as PI3K/AKT and MAPK. These pathways regulate cell growth, survival, and differentiation. HER2 is unique among EGFR family members in that it does not require direct ligand binding and instead functions as a preferred dimerization partner, amplifying signaling activity through receptor interactions.
The extracellular region of HER2 is critical for receptor dimerization and interaction with other signaling partners. Antibodies generated against this portion of the protein are particularly useful for detecting membrane-associated HER2 in tissue sections, where receptor localization and density at the cell surface are key indicators of biological activity. In immunohistochemistry, HER2 is typically observed as strong membranous staining in tumor epithelial cells, reflecting its role as a cell surface receptor.
HER2 expression is frequently elevated in cancers such as breast carcinoma, where ERBB2 gene amplification leads to increased receptor density and enhanced signaling. In these tumors, HER2 detection is used to assess tumor characteristics and study receptor-driven pathways. Expression patterns may vary across tumor regions, with areas of strong membranous staining corresponding to higher receptor expression.
Structurally, HER2 consists of a large extracellular domain, a single transmembrane region, and an intracellular tyrosine kinase domain. The extracellular region mediates receptor interactions, while the intracellular domain drives downstream signaling through phosphorylation events. The ability to detect HER2 within this extracellular portion supports studies focused on receptor localization and cell surface expression.
Protein microarray validation demonstrates specific binding of this antibody to HER2 with minimal off-target interaction, supporting reliable detection of the intended target. Combined with strong immunohistochemistry performance in breast cancer tissue, this antibody provides robust detection of HER2 in studies of tumor biology and receptor expression.
For broad detection of HER2 (ErbB2) as a receptor tyrosine kinase, see our HER2 antibody.
Optimal dilution of the HER2 Antibody / Extracellular Domain Antibody should be determined by the researcher.
A recombinant human HER2 protein fragment within amino acids 311-462 was used as the immunogen for the HER2 antibody. Its epitope is localized in the extracellular domain.
Store the HER2 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
HER2 antibody, ErbB2 antibody, ERBB2 antibody, HER2 extracellular domain antibody, ErbB2 extracellular region antibody
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.